Skip to main content Accessibility help
×
Home
Hostname: page-component-6c8bd87754-fppf4 Total loading time: 1.191 Render date: 2022-01-20T05:02:04.414Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Article contents

Paliperidone Palmitate in Psychogeriatric Patients and New Criteria Stopp-start

Published online by Cambridge University Press:  23 March 2020

I. Martinez Perez*
Affiliation:
Residencia Psicogeriatrica Virgen del Valle, Psiquiatría, Murcia, Spain
F. García Sánchez
Affiliation:
Hospital Universitario Viren de la Salud, Anestesia, Elda, Spain
M.R. Raposo Hernandez
Affiliation:
Hospital Universitario Santa Lucia, Psiquiatría, Cartagena, Spain
A. Gil Sánchez
Affiliation:
Centro Salud Mental Vicente Campillo, Psiquiatría, Murcia, Spain
A.L. Gonzalez Galdamez
Affiliation:
Hospital Universitario Santa Lucia, Psiquiatría, Cartagena, Spain
M.D. Piqueras Acevedo
Affiliation:
Hospital Universitario Santa Lucia, Psiquiatría, Cartagena, Spain
J.M. Lujan Rico
Affiliation:
Residencia Psicogeriatrica Virgen del Valle, Psiquiatría, Murcia, Spain
A. Belmar Simo
Affiliation:
Hospital Universitario Santa Lucia, Psiquiatría, Cartagena, Spain
C.J. Garcia Briñol
Affiliation:
Hospital Universitario Santa Lucia, Psiquiatría, Cartagena, Spain
*
*Corresponding author.
Get access

Abstract

The treatment of psychosis in the elderly should ensure effectiveness and avoid side effects from combination therapy. Long acting antipsychotic as paliperidone palmitate facilitates this work. Furthermore, STOPP-START criteria, first published in 2008 (in Spanish in 2009), are being adopted as reference criteria throughout Europe. The Spanish version of the new 2014 edition is also recently published [1]. A descriptive study of a total of 53 institutionalized patients in psychogeriatric residence (> 60 to 97 years) with psychotic disorder diagnosis and treatment with various neuroleptics is done. In total, 26.4% of the sample admitted to treatment with three different antipsychotics, and 47.1% with combination of two antipsychotics. Only 26.4% worked with antipsychotic monotherapy. In these patients, treatment with paliperidone palmitate starts or sets the previous dose. A CGI scale is applied after six months of treatment. Antipsychotic monotherapy in 66.66% of patients on neuroleptic combination therapy was achieved, so that 75% of the sample currently maintains monotherapy with paliperidone palmitate. The paliperidone palmitate has shown effectiveness in the symptomatic control and reducing the risk of inapropiate prescribing in older patients with psicosis. The paliperidone palmitate allows antipsychotic monotherapy in the psychogeriatric patient with severe mental illness polymedicated as the STOPP-START criteria recommends.

Reference not available.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV734
Copyright
Copyright © European Psychiatric Association 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Submit a response

Comments

No Comments have been published for this article.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Paliperidone Palmitate in Psychogeriatric Patients and New Criteria Stopp-start
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Paliperidone Palmitate in Psychogeriatric Patients and New Criteria Stopp-start
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Paliperidone Palmitate in Psychogeriatric Patients and New Criteria Stopp-start
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *